View source for Interferon gamma-1b (Actimmune)

==General information==
Class/mechanism: Immune system activator; binds to cell surface receptors that modulate many downstream intracellular signal transduction pathways.
<br>Route: SC
<br>Extravasation: no information

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.

==Diseases for which it was used==
*[[Ovarian cancer_-_historical|Ovarian cancer]]

==History of changes in FDA indication==
* 1999-02-25: Initial FDA approval

== Patient Drug Information==
*[https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/103836s5182lbl.pdf Interferon gamma-1b (Actimmune) Package Insert]<ref>[https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/103836s5182lbl.pdf Interferon gamma-1b (Actimmune) Package Insert]</ref>

==Also known as==
*'''Brand name:''' Actimmune

==References==

[[Category:Drugs]]
[[Category:Subcutaneous medications]]

[[Category:Interferon gammas]]

[[Category:Ovarian cancer medications (historic)]]

[[Category:FDA approved in 1999]]